Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$17.43 USD

17.43
643,813

-0.42 (-2.35%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $17.43 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Intuitive Surgical (ISRG) Gains Following Q1 Earnings Beat

by Zacks Equity Research

Intuitive Surgical's (ISRG) first-quarter results reflect healthy demand for procedures, partially offset by unfavorable currency. COVID-19 impacts procedure volume in China.

Zacks Equity Research

Should SPDR S&P 600 Small Cap ETF (SLY) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SLY

Zacks Equity Research

Will AMN Healthcare (AMN) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

3 Reasons to Retain AMN Healthcare (AMN) Stock in Your Portfolio

by Zacks Equity Research

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

Zacks Equity Research

AMN Healthcare Services (AMN) Gains But Lags Market: What You Should Know

by Zacks Equity Research

AMN Healthcare Services (AMN) closed the most recent trading day at $83.06, moving +0.12% from the previous trading session.

Zacks Equity Research

AMN Healthcare Services (AMN) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

AMN Healthcare Services (AMN) closed the most recent trading day at $83.96, moving -1.78% from the previous trading session.

Zacks Equity Research

AMN Healthcare Services (AMN) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, AMN Healthcare Services (AMN) closed at $85.06, marking a +1.69% move from the previous day.

Zacks Equity Research

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Zacks Equity Research

AMN Healthcare Services (AMN) Stock Moves -0.52%: What You Should Know

by Zacks Equity Research

AMN Healthcare Services (AMN) closed at $85.31 in the latest trading session, marking a -0.52% move from the prior day.

Zacks Equity Research

AMN Healthcare Services (AMN) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, AMN Healthcare Services (AMN) closed at $85.89, marking a -1.91% move from the previous day.

Zacks Equity Research

Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SLYG

Zacks Equity Research

Implied Volatility Surging for AMN Healthcare (AMN) Stock Options

by Zacks Equity Research

Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.

Zacks Equity Research

Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VIOG

Zacks Equity Research

CVS Health's (CVS) New Acquisitions Aid, Cost Woes Linger

by Zacks Equity Research

CVS Health (CVS) launches functionality that gives patients more choices and convenience in filling prescriptions.

Zacks Equity Research

Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SPSM

Zacks Equity Research

Teladoc Health (TDOC) Down 8.1% Since Q4 Earnings Release

by Zacks Equity Research

Teladoc Health's (TDOC) fourth-quarter results bear the brunt of escalating expenses. Management expects 2023 revenues within $2,550-$2,675 million, way higher than the 2022 figure.

Zacks Equity Research

IDEXX (IDXX) Global Sales, Instrument Placement Robust

by Zacks Equity Research

IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.

Zacks Equity Research

Select Medical (SEM) Q4 Earnings Miss Estimates, Revenues Up

by Zacks Equity Research

Select Medical (SEM) anticipates 2023 revenues to be within $6.5-$6.7 billion.

Zacks Equity Research

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

Walgreens' (WBA) New Partnerships Aid, Margin Pressure Ails

by Zacks Equity Research

Walgreens Boots (WBA) raises its U.S. Healthcare target, including fiscal 2025 sales goal.

Zacks Equity Research

Quest Diagnostics (DGX) Base Business Growth Robust, Volume Up

by Zacks Equity Research

Quest Diagnostics (DGX) starts to benefit from incentives related to these value-based contracts, which help demonstrate the value of these strategic relationships.

Zacks Equity Research

Medtronic (MDT) Receives CE Mark Approval For Aurora System

by Zacks Equity Research

Medtronic (MDT) Aurora EV-ICD system indicated for patients at risk of life-threatening arrhythmias.

Zacks Equity Research

Pediatrix (MD) Q4 Earnings miss on High Operating Expenses

by Zacks Equity Research

Pediatrix (MD) anticipates 2023 adjusted EBITDA to be within $235-$245 million.

Zacks Equity Research

Here's Why You Should Retain Neogen (NEOG) Stock for Now

by Zacks Equity Research

Investors are optimistic about Neogen's (NEOG) strong performance across its Animal Safety and Food Safety segments.

Zacks Equity Research

Here's Why You Should Retain Abbott (ABT) Stock for Now

by Zacks Equity Research

Investors are optimistic about Abbott (ABT) owing to continued growth in the Diabetes business.